{
    "2021-08-10": [
        [
            {
                "time": "2021-08-15",
                "original_text": "Director of Vaccine Education Center: 'The governor of Florida has served as a friend of SARS-CoV-2 virus'",
                "features": {
                    "keywords": [
                        "governor",
                        "Florida",
                        "SARS-CoV-2",
                        "vaccine"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-08-15",
                "original_text": "‘Now we have to be in the business of saving and protecting lives’: CA State Superintendent of Public Instruction",
                "features": {
                    "keywords": [
                        "saving lives",
                        "protecting",
                        "CA",
                        "Superintendent"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "education",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-07-30",
                "original_text": "Immunovant (IMVT) Reports Wider-Than-Expected Loss in Q1",
                "features": {
                    "keywords": [
                        "Immunovant",
                        "loss",
                        "Q1"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-08-05",
                "original_text": "Halozyme (HALO) Beats on Q2 Earnings, Raises 2021 Guidance",
                "features": {
                    "keywords": [
                        "Halozyme",
                        "earnings",
                        "guidance",
                        "Q2"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}